Individual (single) patient expanded access may be considered.
Patients facing serious or life-threatening illnesses who have exhausted currently available treatment options and are ineligible or unable to participate in a clinical trial may decide to explore therapeutic use of investigational drugs with their healthcare providers. Under these circumstances, single-patient access can be requested from a licensed treating physician on behalf of the patient. Please contact expandedaccess@biocomposites.com for more information.
Study Type
EXPANDED_ACCESS
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.